Birdwatch Archive

Birdwatch Note

2023-05-02 03:52:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Once a drug has been approved for human use, doctors are generally able to prescribe it for any illness. https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label Ivermectin has been approved for human use. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/#:~:text=Ivermectin%20is%20a%20Food%20and,onchocerciasis%2C%20helminthiases%2C%20and%20scabies.&text=For%20these%20indications%2C%20ivermectin%20has,and%20is%20generally%20well%20tolerated.

Written by 1EA7258A808A801310485B6323639526180910D8D193D752AA620CCE313DBB88
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1429050070243192839

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1653246153972916227
  • noteId - 1653246153972916227
  • participantId -
  • noteAuthorParticipantId - 1EA7258A808A801310485B6323639526180910D8D193D752AA620CCE313DBB88 Participant Details
  • createdAtMillis - 1682999573590
  • tweetId - 1429050070243192839
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Once a drug has been approved for human use, doctors are generally able to prescribe it for any illness. https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label Ivermectin has been approved for human use. https://www.covid19treatmentguidelines.nih.gov/therapies/miscellaneous-drugs/ivermectin/#:~:text=Ivermectin%20is%20a%20Food%20and,onchocerciasis%2C%20helminthiases%2C%20and%20scabies.&text=For%20these%20indications%2C%20ivermectin%20has,and%20is%20generally%20well%20tolerated.

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-05-02 03:52:53 UTC
(1682999573590)
1969-12-31 23:59:59 UTC
(-1)
2023-05-06 02:42:24 UTC
(1683340944665)
NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-05-03 08:29:36 -0500 Rating Details
2023-05-03 08:02:34 -0500 Rating Details
2023-05-03 07:03:15 -0500 Rating Details
2023-05-02 17:53:36 -0500 Rating Details
2023-05-02 16:15:53 -0500 Rating Details
2023-05-02 14:56:03 -0500 Rating Details
2023-05-02 14:50:55 -0500 Rating Details
2023-05-02 14:03:49 -0500 Rating Details
2023-05-02 13:53:10 -0500 Rating Details
2023-05-02 12:48:06 -0500 Rating Details
2023-05-02 12:45:57 -0500 Rating Details
2023-05-02 12:35:22 -0500 Rating Details
2023-05-02 12:00:55 -0500 Rating Details
2023-05-02 11:52:38 -0500 Rating Details
2023-05-02 11:25:16 -0500 Rating Details
2023-05-02 11:16:07 -0500 Rating Details
2023-05-02 11:06:08 -0500 Rating Details
2023-05-02 11:02:52 -0500 Rating Details
2023-05-02 10:50:48 -0500 Rating Details
2023-05-02 10:43:59 -0500 Rating Details
2023-05-02 10:41:57 -0500 Rating Details
2023-05-02 10:40:05 -0500 Rating Details
2023-05-02 10:30:17 -0500 Rating Details
2023-05-02 09:47:09 -0500 Rating Details
2023-05-02 08:58:10 -0500 Rating Details
2023-05-02 08:01:08 -0500 Rating Details
2023-05-02 07:37:02 -0500 Rating Details
2023-05-02 07:36:27 -0500 Rating Details
2023-05-02 07:04:53 -0500 Rating Details
2023-05-02 06:30:53 -0500 Rating Details
2023-05-02 06:29:59 -0500 Rating Details
2023-05-02 05:13:16 -0500 Rating Details
2023-05-02 04:41:49 -0500 Rating Details
2023-05-02 04:33:11 -0500 Rating Details
2023-05-02 04:31:48 -0500 Rating Details
2023-05-02 04:24:48 -0500 Rating Details
2023-05-02 03:58:20 -0500 Rating Details
2023-05-02 03:44:06 -0500 Rating Details
2023-05-02 03:43:10 -0500 Rating Details
2023-05-02 03:41:29 -0500 Rating Details
2023-05-02 03:39:11 -0500 Rating Details
2023-05-02 03:37:18 -0500 Rating Details
2023-05-02 03:31:37 -0500 Rating Details
2023-05-02 03:24:44 -0500 Rating Details
2023-05-02 03:05:41 -0500 Rating Details
2023-05-02 02:51:06 -0500 Rating Details
2023-05-02 02:32:32 -0500 Rating Details
2023-05-02 02:11:26 -0500 Rating Details
2023-05-02 01:53:04 -0500 Rating Details
2023-05-02 01:45:27 -0500 Rating Details
2023-05-01 23:12:24 -0500 Rating Details
2023-05-01 23:09:46 -0500 Rating Details
2023-05-17 22:08:15 -0500 Rating Details
2023-05-17 21:38:52 -0500 Rating Details
2023-05-17 22:08:15 -0500 Rating Details
2023-05-02 14:56:03 -0500 Rating Details
2023-05-02 10:30:17 -0500 Rating Details
2023-05-02 03:41:29 -0500 Rating Details
2023-05-02 03:58:20 -0500 Rating Details
2023-05-02 03:05:41 -0500 Rating Details
2023-05-01 23:09:46 -0500 Rating Details
2023-05-02 12:35:22 -0500 Rating Details
2023-05-02 03:44:06 -0500 Rating Details
2023-05-03 08:29:36 -0500 Rating Details
2023-05-02 14:50:55 -0500 Rating Details
2023-05-02 12:48:06 -0500 Rating Details
2023-05-02 16:15:53 -0500 Rating Details
2023-05-02 04:41:49 -0500 Rating Details
2023-05-02 10:50:48 -0500 Rating Details
2023-05-02 02:51:06 -0500 Rating Details
2023-05-02 03:39:11 -0500 Rating Details
2023-05-02 10:41:57 -0500 Rating Details
2023-05-17 21:38:52 -0500 Rating Details
2023-05-02 01:45:27 -0500 Rating Details
2023-05-02 05:13:16 -0500 Rating Details
2023-05-02 06:30:53 -0500 Rating Details
2023-05-02 11:25:16 -0500 Rating Details
2023-05-02 07:04:53 -0500 Rating Details
2023-05-02 02:32:32 -0500 Rating Details
2023-05-02 13:53:10 -0500 Rating Details
2023-05-02 03:43:10 -0500 Rating Details
2023-05-02 04:31:48 -0500 Rating Details
2023-05-02 10:43:59 -0500 Rating Details
2023-05-02 06:29:59 -0500 Rating Details
2023-05-01 23:12:24 -0500 Rating Details
2023-05-02 01:53:04 -0500 Rating Details
2023-05-02 11:16:07 -0500 Rating Details
2023-05-02 12:00:55 -0500 Rating Details
2023-05-02 07:37:02 -0500 Rating Details
2023-05-03 08:02:34 -0500 Rating Details
2023-05-02 08:01:08 -0500 Rating Details
2023-05-02 10:40:05 -0500 Rating Details
2023-05-02 07:36:27 -0500 Rating Details
2023-05-02 08:58:10 -0500 Rating Details
2023-05-02 04:24:48 -0500 Rating Details
2023-05-02 12:45:57 -0500 Rating Details
2023-05-02 17:53:36 -0500 Rating Details
2023-05-03 07:03:15 -0500 Rating Details
2023-05-02 04:33:11 -0500 Rating Details
2023-05-02 03:37:18 -0500 Rating Details
2023-05-02 11:52:38 -0500 Rating Details
2023-05-02 11:02:52 -0500 Rating Details
2023-05-02 03:31:37 -0500 Rating Details
2023-05-02 03:24:44 -0500 Rating Details
2023-05-02 11:06:08 -0500 Rating Details
2023-05-02 14:03:49 -0500 Rating Details
2023-05-02 09:47:09 -0500 Rating Details
2023-05-02 02:11:26 -0500 Rating Details
2023-05-22 09:30:19 -0500 Rating Details
2023-05-22 18:19:10 -0500 Rating Details
2023-06-08 09:43:32 -0500 Rating Details
2023-06-25 08:40:51 -0500 Rating Details
2023-07-26 10:31:56 -0500 Rating Details
2023-08-11 18:11:50 -0500 Rating Details
2023-08-11 14:40:14 -0500 Rating Details
2023-08-11 09:27:03 -0500 Rating Details
2023-08-11 09:24:35 -0500 Rating Details
2023-08-11 06:56:26 -0500 Rating Details
2023-08-13 16:15:30 -0500 Rating Details
2023-08-13 12:38:59 -0500 Rating Details
2023-08-13 10:58:07 -0500 Rating Details
2023-08-13 07:16:49 -0500 Rating Details
2023-08-13 06:39:42 -0500 Rating Details
2023-08-13 04:29:00 -0500 Rating Details
2023-08-13 03:08:22 -0500 Rating Details
2023-08-12 23:15:58 -0500 Rating Details
2023-08-12 21:00:56 -0500 Rating Details
2023-08-12 20:11:18 -0500 Rating Details
2023-08-12 19:48:11 -0500 Rating Details
2023-08-12 18:56:09 -0500 Rating Details
2023-08-12 16:32:17 -0500 Rating Details
2023-08-12 16:24:25 -0500 Rating Details
2023-08-12 13:48:38 -0500 Rating Details
2023-08-12 08:27:52 -0500 Rating Details
2023-08-12 07:03:50 -0500 Rating Details
2023-08-13 22:34:23 -0500 Rating Details
2023-08-15 12:29:22 -0500 Rating Details
2023-08-15 12:14:23 -0500 Rating Details
2023-08-15 11:35:35 -0500 Rating Details
2023-08-15 09:53:44 -0500 Rating Details
2023-08-16 17:58:09 -0500 Rating Details
2023-08-16 13:23:45 -0500 Rating Details
2023-08-17 16:28:32 -0500 Rating Details
2023-08-14 22:00:12 -0500 Rating Details
2023-08-13 11:08:07 -0500 Rating Details
2023-08-13 08:34:52 -0500 Rating Details
2023-08-13 07:41:36 -0500 Rating Details
2023-08-13 07:34:27 -0500 Rating Details
2023-08-12 22:58:36 -0500 Rating Details
2023-08-12 18:57:57 -0500 Rating Details
2023-08-12 15:25:03 -0500 Rating Details
2023-08-12 09:17:30 -0500 Rating Details
2023-08-12 08:16:00 -0500 Rating Details
2023-08-26 12:44:41 -0500 Rating Details
2023-12-03 20:09:49 -0600 Rating Details
2023-12-18 23:26:58 -0600 Rating Details
2024-02-01 15:32:41 -0600 Rating Details
2024-02-11 08:52:23 -0600 Rating Details
2024-03-08 17:32:41 -0600 Rating Details
2024-03-09 19:53:53 -0600 Rating Details
2024-03-22 21:25:40 -0500 Rating Details
2024-03-22 20:50:55 -0500 Rating Details
2024-03-22 19:27:54 -0500 Rating Details
2024-03-22 17:34:36 -0500 Rating Details
2024-03-22 15:24:18 -0500 Rating Details
2024-03-22 13:08:15 -0500 Rating Details
2024-03-22 12:48:13 -0500 Rating Details
2024-03-22 10:22:32 -0500 Rating Details
2024-03-22 08:31:34 -0500 Rating Details
2024-03-23 18:17:22 -0500 Rating Details
2024-03-23 07:52:55 -0500 Rating Details
2024-03-23 02:57:09 -0500 Rating Details
2024-03-23 02:33:27 -0500 Rating Details
2024-03-23 00:53:42 -0500 Rating Details
2024-03-22 22:33:26 -0500 Rating Details
2024-03-23 21:33:24 -0500 Rating Details
2024-03-23 16:58:14 -0500 Rating Details
2024-03-23 14:44:29 -0500 Rating Details
2024-03-23 08:30:30 -0500 Rating Details
2024-03-23 05:25:59 -0500 Rating Details
2024-03-23 02:25:45 -0500 Rating Details
2024-03-23 01:49:43 -0500 Rating Details
2024-03-22 21:14:41 -0500 Rating Details
2024-03-22 20:33:45 -0500 Rating Details
2024-03-22 19:08:19 -0500 Rating Details
2024-03-22 17:58:51 -0500 Rating Details
2024-03-22 17:43:49 -0500 Rating Details
2024-03-22 14:19:58 -0500 Rating Details
2024-03-22 13:57:34 -0500 Rating Details
2024-03-22 12:37:01 -0500 Rating Details
2024-03-22 08:22:07 -0500 Rating Details
2024-03-22 07:01:51 -0500 Rating Details
2024-03-14 08:14:10 -0500 Rating Details
2024-03-11 18:17:09 -0500 Rating Details
2024-03-23 06:39:28 -0500 Rating Details
2024-03-23 05:34:40 -0500 Rating Details
2024-03-22 20:10:47 -0500 Rating Details
2024-03-22 19:37:46 -0500 Rating Details
2024-03-22 18:26:02 -0500 Rating Details
2024-03-22 17:54:37 -0500 Rating Details
2024-03-22 15:18:51 -0500 Rating Details
2024-03-22 13:33:34 -0500 Rating Details
2024-03-22 12:02:57 -0500 Rating Details
2024-03-22 07:30:46 -0500 Rating Details
2024-03-22 02:35:27 -0500 Rating Details
2024-03-22 01:48:30 -0500 Rating Details
2024-03-22 01:48:11 -0500 Rating Details
2024-03-31 20:11:05 -0500 Rating Details
2024-03-31 17:03:32 -0500 Rating Details
2024-03-31 16:36:09 -0500 Rating Details
2024-04-02 02:06:24 -0500 Rating Details
2024-04-01 16:12:44 -0500 Rating Details
2024-04-01 11:28:48 -0500 Rating Details
2024-04-01 02:07:22 -0500 Rating Details
2024-03-31 22:57:23 -0500 Rating Details